CLSD logo

Clearside Biomedical (CLSD) EBITDA

Annual EBITDA

-$23.06 M
+$6.41 M+21.74%

December 31, 2023

Summary

Performance

1-Year Change

+21.74%

3-Year Change

-27.89%

5-Year Change

+72.14%

15-Year Change

+60.4%

CLSD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.4%
CLSD annual EBITDA is higher than 49.4% of companies in Healthcare sector

High & Low

All-time High

$554.00 K
CLSD annual EBITDA is currently -4262.09% below its historical high of $554.00 thousand

3-Year Low

-$29.46 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CLSD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 12, 2025
CLSD next annual earnings announcement is scheduled for Mar 12, 2025

OtherCLSDprofitabilitymetrics:

Annual Revenue

$8.23 M
CLSD annual revenue is $8.23 million

Annual Net Income

-$32.48 M
CLSD annual net profit is -$32.48 million

Annual EBIT

-$23.13 M
CLSD annual earnings before interest & taxes is -$23.13 million

Annual EPS

-$0.53
CLSD annual earnings per share is -$0.53

Quarterly EBITDA

-$5.16 M
+$54.00 K+1.04%

September 30, 2024

Summary

Performance

3-Month Change

+1.04%

1-Year Change

+22.22%

3-Year Change

+22.22%

5-Year Change

+22.22%

CLSD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.12%
CLSD quarterly EBITDA is higher than 47.12% of companies in Healthcare sector

High & Low

All-time High

$18.75 M
CLSD quarterly EBITDA is currently -127.49% below its historical high of $18.75 million

3-Year Low

-$9.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CLSD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
CLSD next earnings announcement is scheduled for Mar 12, 2025

OtherCLSDprofitabilitymetrics:

Quarterly Revenue

$1.04 M
CLSD quarterly revenue is $1.04 million

Quarterly Net Income

-$7.69 M
CLSD quarterly net profit is -$7.69 million

Quarterly EBIT

-$5.23 M
CLSD quarterly earnings before interest & taxes is -$5.23 million

Quarterly EPS

-$0.10
CLSD quarterly earnings per share is -$0.10

TTM EBITDA

-$22.23 M
+$1.47 M+6.21%

September 30, 2024

Summary

Performance

3-Month Change

+6.21%

1-Year Change

+20.94%

3-Year Change

+20.94%

5-Year Change

+20.94%

CLSD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.63%
CLSD TTM EBITDA is higher than 47.63% of companies in Healthcare sector

High & Low

All-time High

$261.00 K
CLSD TTM EBITDA is currently -8618.39% below its historical high of $261.00 thousand

3-Year Low

-$29.46 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CLSD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
CLSD next earnings announcement is scheduled for Mar 12, 2025

OtherCLSDprofitabilitymetrics:

TTM Revenue

$7.70 M
CLSD TTM revenue is $7.70 million

TTM Net Income

-$31.88 M
CLSD TTM net profit is -$31.88 million

TTM EBIT

-$22.40 M
CLSD TTM earnings before interest & taxes is -$22.40 million

TTM EPS

-$0.45
CLSD TTM earnings per share is -$0.45

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$23.06 M
CLSD annual EBITDA is -$23.06 million

Annual Net Income

-$32.48 M
CLSD annual net profit is -$32.48 million

Annual Interest Expense

$9.36 M
CLSD annual interest expense is $9.36 million

Annual Income Tax

-
CLSD annual income tax value is unknown

Annual D&A

$67.00 K
CLSD annual depreciation & amortization is $67.00 thousand

CLSD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.7%+22.2%+20.9%
3 y3 years-27.9%+22.2%+20.9%
5 y5 years+72.1%+22.2%+20.9%

CLSD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4262.1%+21.7%-127.5%+44.8%-8618.4%+24.5%
5 y5-year-4262.1%+23.4%-127.5%+44.8%-8618.4%+26.1%
alltimeall time-4262.1%+72.1%-127.5%+78.4%-8618.4%+73.1%

Clearside Biomedical EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.16 M(-1.0%)
-$22.23 M(-6.2%)
Jun 2024
-
-$5.21 M(-44.2%)
-$23.71 M(-6.3%)
Mar 2024
-
-$9.33 M(+268.1%)
-$25.29 M(+9.7%)
Dec 2023
-$23.06 M(-21.7%)
-$2.54 M(-61.8%)
-$23.06 M(-18.0%)
Sep 2023
-
-$6.63 M(-2.5%)
-$28.12 M(+0.5%)
Jun 2023
-
-$6.80 M(-4.3%)
-$27.98 M(-3.4%)
Mar 2023
-
-$7.10 M(-6.6%)
-$28.96 M(-1.7%)
Dec 2022
-$29.46 M(-5418.2%)
-$7.60 M(+17.1%)
-$29.46 M(+847.4%)
Sep 2022
-
-$6.49 M(-16.5%)
-$3.11 M(+112.7%)
Jun 2022
-
-$7.78 M(+2.3%)
-$1.46 M(-660.2%)
Mar 2022
-
-$7.60 M(-140.5%)
$261.00 K(-158.7%)
Dec 2021
$554.00 K(-103.1%)
$18.75 M(-487.2%)
-$445.00 K(-98.3%)
Sep 2021
-
-$4.84 M(-20.0%)
-$26.54 M(+10.2%)
Jun 2021
-
-$6.05 M(-27.1%)
-$24.08 M(+2.3%)
Mar 2021
-
-$8.30 M(+13.1%)
-$23.54 M(+30.6%)
Dec 2020
-$18.03 M(-40.1%)
-$7.34 M(+207.7%)
-$18.03 M(+32.1%)
Sep 2020
-
-$2.39 M(-56.7%)
-$13.65 M(-22.3%)
Jun 2020
-
-$5.51 M(+97.5%)
-$17.58 M(-0.3%)
Mar 2020
-
-$2.79 M(-5.8%)
-$17.63 M(-41.4%)
Dec 2019
-$30.09 M
-$2.96 M(-53.1%)
-$30.09 M(-38.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$6.32 M(+13.5%)
-$48.72 M(-26.5%)
Jun 2019
-
-$5.56 M(-63.5%)
-$66.31 M(-18.7%)
Mar 2019
-
-$15.25 M(-29.3%)
-$81.60 M(-1.4%)
Dec 2018
-$82.76 M(+42.1%)
-$21.58 M(-9.7%)
-$82.76 M(+6.9%)
Sep 2018
-
-$23.91 M(+14.6%)
-$77.45 M(+8.0%)
Jun 2018
-
-$20.86 M(+27.1%)
-$71.68 M(+11.3%)
Mar 2018
-
-$16.41 M(+0.8%)
-$64.41 M(+10.6%)
Dec 2017
-$58.23 M(+131.7%)
-$16.27 M(-10.3%)
-$58.23 M(+13.5%)
Sep 2017
-
-$18.14 M(+33.6%)
-$51.29 M(+33.4%)
Jun 2017
-
-$13.58 M(+32.8%)
-$38.44 M(+28.0%)
Mar 2017
-
-$10.23 M(+9.5%)
-$30.02 M(+19.4%)
Dec 2016
-$25.13 M(+45.6%)
-$9.34 M(+76.6%)
-$25.13 M(+20.9%)
Sep 2016
-
-$5.29 M(+2.4%)
-$20.79 M(+10.2%)
Jun 2016
-
-$5.16 M(-3.3%)
-$18.86 M(+0.0%)
Mar 2016
-
-$5.34 M(+6.8%)
-$18.86 M(+9.3%)
Dec 2015
-$17.26 M(+76.3%)
-$5.00 M(+48.8%)
-$17.25 M(+15.9%)
Sep 2015
-
-$3.36 M(-34.8%)
-$14.89 M(+29.1%)
Jun 2015
-
-$5.15 M(+37.9%)
-$11.53 M(+80.8%)
Mar 2015
-
-$3.74 M(+41.6%)
-$6.38 M(+141.6%)
Dec 2014
-$9.79 M(+35.7%)
-$2.64 M
-$2.64 M
Dec 2013
-$7.22 M
-
-

FAQ

  • What is Clearside Biomedical annual EBITDA?
  • What is the all time high annual EBITDA for Clearside Biomedical?
  • What is Clearside Biomedical annual EBITDA year-on-year change?
  • What is Clearside Biomedical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Clearside Biomedical?
  • What is Clearside Biomedical quarterly EBITDA year-on-year change?
  • What is Clearside Biomedical TTM EBITDA?
  • What is the all time high TTM EBITDA for Clearside Biomedical?
  • What is Clearside Biomedical TTM EBITDA year-on-year change?

What is Clearside Biomedical annual EBITDA?

The current annual EBITDA of CLSD is -$23.06 M

What is the all time high annual EBITDA for Clearside Biomedical?

Clearside Biomedical all-time high annual EBITDA is $554.00 K

What is Clearside Biomedical annual EBITDA year-on-year change?

Over the past year, CLSD annual EBITDA has changed by +$6.41 M (+21.74%)

What is Clearside Biomedical quarterly EBITDA?

The current quarterly EBITDA of CLSD is -$5.16 M

What is the all time high quarterly EBITDA for Clearside Biomedical?

Clearside Biomedical all-time high quarterly EBITDA is $18.75 M

What is Clearside Biomedical quarterly EBITDA year-on-year change?

Over the past year, CLSD quarterly EBITDA has changed by +$1.47 M (+22.22%)

What is Clearside Biomedical TTM EBITDA?

The current TTM EBITDA of CLSD is -$22.23 M

What is the all time high TTM EBITDA for Clearside Biomedical?

Clearside Biomedical all-time high TTM EBITDA is $261.00 K

What is Clearside Biomedical TTM EBITDA year-on-year change?

Over the past year, CLSD TTM EBITDA has changed by +$5.89 M (+20.94%)